1,3-Di-HABA Kanamycin A is a chemical compound used as an intermediate in the manufacturing of aminoglycoside antibiotics. It features a complex, flexible molecular structure with multiple hydroxyl and amine groups, typical of aminoglycoside derivatives.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 927821-99-6
(2S)-4-amino-N-[(1R,4R,5R)-5-amino-4-[(2R,4R,5S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-2-[(2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
pharmaceutical raw material
1,3''-Di-HABA Kanamycin A
Aminoglycoside antibiotic impurity
1,6'-Di-HABA Kanamycin A
amikacin impurity reference standard
(S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxycyclohexyl)-2-hydroxybutanamide
Amikacin impurity reference standard
Lanifibranor
pan-PPAR agonist for NASH
Flomoxef sodium
Active pharmaceutical ingredient
Nintedanib
kinase inhibitor active pharmaceutical ingredient
Canagliflozine hémihydraté
sodium-glucose transport protein subtype 2 inhibitor
(2S)-4-amino-N-[(1R,2S,5S)-2-[(2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[[(2S)-4-amino-2-hydroxybutanoyl]amino]-4-[(2R,5S)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
HVNATBKIPCIZAA-DCOVVSKJSA-N
C1[C@H]([C@@H](C(C([C@H]1NC(=O)[C@H](CCN)O)O[C@@H]2C(C([C@@H](C(O2)CN)O)O)O)O)O[C@@H]3C([C@H]([C@@H](C(O3)CO)O)N)O)NC(=O)[C@H](CCN)O